Guest: Monique A. Freund, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes and pharmacologic therapy has proven effective in reducing the complications of cardiovascular disease. Despite this, it’s estimated that less than 35% of those patients with hyperlipidemia are adequately managed. Why aren’t we doing a better job at managing this major public health problem? In this podcast, we’ll be speaking with Monique A. Freund, M.D., a cardiologist at Mayo Clinic. We’ll discuss how to optimize management of hyperlipidemia, which lifestyle changes are beneficial, when to use pharmacologic therapy and how to manage patients with statin intolerance.
- Relative importance of elevated LDLc, low HDLc and elevated triglycerides
- Effective non-pharmacologic therapy for treating elevated LDLc, low HDLc and elevated triglycerides
- When to consider starting a patient on a statin
- Benefits of fish oil
- Mechanism of action of statins
- Statin intolerance
- When to use ezetimibe
- When to use one of the PCSK9-inhibitors
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.